Back

Impact of beta-blockers after myocardial infarction in patients with preserved or mildly reduced left ventricular ejection fraction: a meta-analysis of randomised trials

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Contemporary beta‑blocker pharmacotherapy Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Leonardo Neira Chunga

Santa Maria Health Center I-3, Yurimaguas (Peru)

7 More presentations in this session

Presentation thumbnail
Metoprolol versus bisoprolol in patients with acute myocardial infarction: a target trial emulation study
Doctor T. Yang (Tianjin, CN)
Abstract
Presentation thumbnail
β-blocker adherence trajectories and 5-year clinical outcomes in PCI-treated ACS patients with LVEF ≥50%: a group-based trajectory modeling analysis
Professor M. Qiu (Shenyang, CN)
Abstract
Presentation thumbnail
In-hospital beta-blocker initiation is associated with improved survival in AF-HFpEF with tachycardia
Doctor S. Naito (JP)
Abstract
Presentation thumbnail
Beta-blocker therapy after myocardial infarction in the PCI Era: an updated meta-analysis
Doctor J. Aleman (Cebu City, PH)
Abstract
Presentation thumbnail
The range of left ventricular ejection fraction associated with survival benefit from beta-blockers
Professor J. Choi (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Contemporary beta‑blocker pharmacotherapy

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
The need and duration of BB therapy in post MI patients with preserved left ventricular ejection fraction: a meta-analysis
27 August 2021
thumbnail
Congress Presentation
SGLT2 inhibitors in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis
7 April 2022
thumbnail
Congress Presentation
Preventive strategies for anthracyclines and trastuzumab induced cardiotoxicity: a systematic review and meta-analysis
29 June 2021
thumbnail
Congress Presentation
Prognostic value of LVEF in patients undergoing TAVI: a meta-analysis of 75,085 patients
13 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources